Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.251)

1

Timing of onset of menses after GnRH agonist treatment for central precocious puberty

enthalten in: Journal of pediatric endocrinology & metabolism : JPEM | 2024

von Klein, K. | Vargas Trujillo, M. | Dragnic, S. | +3

2

Small Effects, Questionable Outcomes : Bremelanotide for Hypoactive Sexual Desire Disorder

enthalten in: Journal of sex research | 2024

von Spielmans, G. | Ellefson, E.

3

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer : Patient-reported outcomes in ECOG-ACRIN EA1131

enthalten in: Cancer | 2024

von Smith, K. | Zhao, F. | Mayer, I. | +22

4

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal : an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

enthalten in: The Lancet. Global health | 2024

von Song, K. | Chapagain, R. | Tamrakar, D. | +24

5

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2024

von Machiels, J. | Tao, Y. | Licitra, L. | +125

6

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC : exploratory analysis from KEYNOTE-522

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Pusztai, L. | Denkert, C. | O'Shaughnessy, J. | +16

7

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP) : a randomised, open-label, phase 3, non-inferiority trial

enthalten in: The Lancet. Haematology | 2024

von Stelljes, M. | Middeke, J. | Bug, G. | +94

8

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect : A secondary analysis of NRG CC001

enthalten in: Neuro-oncology | 2024

von Cherng, H. | Sun, K. | Bentzen, S. | +5

9

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Zhong, H. | Sun, S. | Chen, J. | +41

10

Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Hudgens, S. | Verstovsek, S. | Floden, L. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2226]